Vincerx Pharma, Inc. Assets, Fair Value Disclosure
Vincerx Pharma, Inc. had Assets, Fair Value Disclosure of $9.68 million as of 2024-09-30, per its 10-Q filed 2024-11-12.
Financial Statements › Notes
us-gaap:AssetsFairValueDisclosure · last filed 2025-03-27
- 2024-09-30: Assets, Fair Value Disclosure $9.68M.
- 2024-06-30: Assets, Fair Value Disclosure $15.12M.
- 2023-12-31: Assets, Fair Value Disclosure $11.91M.
- 2023-09-30: Assets, Fair Value Disclosure $18.72M.
| Period end | Assets, Fair Value Disclosure |
|---|---|
| 2024-09-30 | $9.68M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $15.12M 10-Q · filed 2024-08-08 |
| 2023-12-31 | $11.91M 10-K · filed 2025-03-27 |
| 2023-09-30 | $18.72M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $25.45M 10-Q · filed 2023-08-07 |
| 2023-03-31 | $36.59M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $50.59M 10-K · filed 2024-03-29 |
| 2022-09-30 | $50.12M 10-Q · filed 2022-11-10 |